Research Article

Tenofovir Disoproxil Fumarate Is Associated with a Set-Point Variation in the Calcium-Parathyroid Hormone-Vitamin D Axis: Results from a German Cohort

Table 1

Patient characteristics of groups with and without TDF-containing ART.

UnitTDF ()Non-TDF () value

AgeYears (IQR)47 (38–53)50 (42–58)<0.001
MaleN (%)429 (76.1)357 (81.5)0.038
African ethnicityN (%)91 (16.1)33 (7.5)<0.001
Missing dataN (%)1 (0.2)0 (0.0)
Creatinine (S)mg/dL (IQR)0.95 (0.82–1.07)1.00 (0.86–1.11)<0.001
25(OH)D (S)ng/mL (IQR)23.0 (14.9–31.1)23.6 (16.5–30.4)0.366
25(OH)D < 20 ng/mLN (%)230 (40.8)165 (37.7)0.998
Total calcium (S)mmol/L (IQR)2.22 (2.16–2.28)2.25 (2.18–2.31)<0.001
Albumin-corrected calciummmol/L (IQR)2.20 (2.14–2.26)2.22 (2.17–2.28)<0.001
Albumin-corrected calcium < 2.12 mmol/LN (%)96 (17.0)43 (9.8)0.001
Phosphatemg/dL (IQR)3.4 (3.0–3.8)3.4 (3.0–3.8)0.392
PTH (S)pg/mL (IQR)44.3 (29.9–61.9)33.7 (22.5–49.3)<0.001
Elevated PTHN (%)121 (21.5)46 (10.5)<0.001
C-terminal telopeptides of collagen type 1 (S)µg/L (IQR)0.38 (0.25–0.52)0.28 (0.20–0.42)<0.001
Elevated C-terminal telopeptides of collagen type 1N (%)49 (8.7)25 (5.7)0.074
Alkaline phosphatase (S)U/L (IQR)83 (68–101)74 (61–93)<0.001